Tert-butyl 4-[1-(6-bromo-1H-benzimidazol-2-yl)-1-cyanoethyl]-5-methoxy-7-methylindole-1-carboxylate
C25H25BrN4O3 — CID 118359939
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[1-(6-bromo-1H-benzimidazol-2-yl)-1-cyanoethyl]-5-methoxy-7-methylindole-1-carboxylate
Tert-butyl 4-[1-(6-bromo-1H-benzimidazol-2-yl)-1-cyanoethyl]-5-methoxy-7-methylindole-1-carboxylate (PubChem CID 118359939) has the molecular formula C25H25BrN4O3 and a molecular weight of 509.40 g/mol. Its IUPAC name is tert-butyl 4-[1-(6-bromo-1H-benzimidazol-2-yl)-1-cyanoethyl]-5-methoxy-7-methylindole-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[1-(6-bromo-1H-benzimidazol-2-yl)-1-cyanoethyl]-5-methoxy-7-methylindole-1-carboxylate |
|---|---|
| PubChem CID | 118359939 |
| Molecular Formula | C25H25BrN4O3 |
| Molecular Weight | 509.40 g/mol |
| Exact Mass | 508.11 |
| IUPAC Name | tert-butyl 4-[1-(6-bromo-1H-benzimidazol-2-yl)-1-cyanoethyl]-5-methoxy-7-methylindole-1-carboxylate |
| SMILES | COc1cc(C)c2c(ccn2C(=O)OC(C)(C)C)c1C(C)(C#N)c1nc2ccc(Br)cc2[nH]1 |
| InChI | InChI=1S/C25H25BrN4O3/c1-14-11-19(32-6)20(16-9-10-30(21(14)16)23(31)33-24(2,3)4)25(5,13-27)22-28-17-8-7-15(26)12-18(17)29-22/h7-12H,1-6H3,(H,28,29) |
| InChIKey | LXYIJCJVLOODLA-UHFFFAOYSA-N |
| XLogP | 6.21 |
| TPSA | 92.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 509.40 |
| LogP ≤ 5 | 6.21 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118359939 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.